Literature DB >> 7694664

Separation, enrichment, and characterization of human hematopoietic progenitor cells from umbilical cord blood.

J H Falkenburg1, S A van Luxemburg-Heijs, J M Zijlmans, W E Fibbe, J C Kluin-Nelemans, H H Kanhai, R Willemze.   

Abstract

Human umbilical cord blood (UCB) may be used as an alternative source of bone marrow repopulating cells in allogeneic bone marrow transplantation in children. It has been reported that high numbers of hematopoietic progenitor cells (HPC) from umbilical cord blood may be lost during simple cell-separation techniques. This may seriously hamper the use of UCB as an alternative source of bone marrow repopulating cells. In this study we demonstrate that UCB can be separated into various cell fractions using several cell-separation methods including red blood cell lysis, methylcellulose sedimentation, and density gradients without significant loss of HPC, when cell separations are initiated within 8 h. We demonstrate that UCB contains a high concentration of immature HPC as compared with bone marrow grafts. Using FACS analysis of cells harvested from single colonies derived from single cell- single well-sorted CD34++ CD33- UCB cells, the high frequency of multipotential HPC was illustrated. These results suggest that UCB may contain sufficient HPC for hematopoietic stem cell transplantation in adults.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694664     DOI: 10.1007/bf01715053

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  16 in total

1.  HLA-mismatched cord-blood transplantation in a patient with advanced leukemia.

Authors:  E Vilmer; G Sterkers; C Rahimy; E Denamur; J Elion; A Broyart; B Lescoeur; J M Tiercy; J Gerota; P Blot
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

2.  Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

Authors:  J M Goldman; R P Gale; M M Horowitz; J C Biggs; R E Champlin; E Gluckman; R G Hoffmann; S J Jacobsen; A M Marmont; P B McGlave
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

Review 3.  Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation.

Authors:  H E Broxmeyer; J Kurtzberg; E Gluckman; A D Auerbach; G Douglas; S Cooper; J H Falkenburg; J Bard; E A Boyse
Journal:  Blood Cells       Date:  1991

Review 4.  Allogenic bone marrow transplantation: current status and future directions.

Authors:  R J O'Reilly
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

5.  Characterization of erythroid and granulocyte monocyte progenitors in human cord blood.

Authors:  S Issaragrisil; G Grilli; W Nothdurft; T M Fliedner
Journal:  Scand J Haematol       Date:  1984-09

6.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Authors:  H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Growth of human umbilical-cord blood in longterm haemopoietic cultures.

Authors:  J M Hows; B A Bradley; J C Marsh; T Luft; L Coutinho; N G Testa; T M Dexter
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

8.  Transplantation of umbilical cord blood in neuroblastoma.

Authors:  P Vanlemmens; E Plouvier; D Amsallem; E Racadot; M L Deschaseaux; J P Schaal; P Charbord; A Noir; P Hervé
Journal:  Nouv Rev Fr Hematol       Date:  1992

9.  Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment.

Authors:  J E Wagner; H E Broxmeyer; R L Byrd; B Zehnbauer; B Schmeckpeper; N Shah; C Griffin; P D Emanuel; K S Zuckerman; S Cooper
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

10.  Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential.

Authors:  L Lu; M Xiao; R N Shen; S Grigsby; H E Broxmeyer
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.